Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate

Molecular Medicine Reports

Volumn 12, Issue 6, 2015, Pages 7899-7906

  Li, Ping ^a   Luo, Shike ^b   Pan, Chunji ^a   Cheng, Xiaoshu ^a  

^a NANCHANG UNIVERSITY   (China)

^b GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

Fenofibrate; Heart failure; Isoproterenol; Peroxisome proliferator activated receptor; Uncoupling protein 2

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; FATTY ACID; FENOFIBRATE; ISOPRENALINE; LACTIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PYRUVIC ACID; UNCOUPLING PROTEIN 2; ANTILIPEMIC AGENT; ION CHANNEL; MITOCHONDRIAL PROTEIN; REACTIVE OXYGEN METABOLITE; UCP2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; GLUCOSE METABOLISM; HEART FAILURE; HEART FUNCTION; HEART INJURY; HEART MUSCLE CELL; IN VITRO STUDY; INVESTIGATIVE PROCEDURES; LACTATE BLOOD LEVEL; MALE; NEWBORN; NONHUMAN; RAT; SUPERNATANT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE CELL; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; NECROSIS; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; ENERGY METABOLISM; FATTY ACIDS; FENOFIBRATE; HEART FAILURE; HYPOLIPIDEMIC AGENTS; ION CHANNELS; ISOPROTERENOL; MALE; MITOCHONDRIAL PROTEINS; MYOCYTES, CARDIAC; NECROSIS; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; UNCOUPLING PROTEIN 2;

EID: 84946743210     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4466     Document Type: Article

References (29)

1. Stewart S, MacIntyre K, Capewell S and McMurray JJ: Heart failure and the aging population: An increasing burden in the 21st century?. Heart 89: 49-53, 2003.
2. Bettari L, Fiuzat M, Felker GM and O'Connor CM: Significance of hyponatremia in heart failure. Heart Fail Rev 17: 17-26, 2012.
3. Dayer M and Cowie MR: Heart failure: Diagnosis and healthcare burden. Clin Med 4: 13-18, 2004.
4. Sinatra ST: Metabolic cardiology: The missing link in cardiovascular disease. Altern Ther Health Med 15: 48-50, 2009.
5. Herrmann G and G D: The chemical nature of heart failure. Ann Intern Med 12: 1233-1244, 1939.
6. Neubauer S: The failing heart-an engine out of fuel. N Engl J Med 356: 1140-1151, 2007.
7. J I: ATP and the heart [M]. Kluwer academic publishers USA: pp197-pp216, 2002.
8. Nagoshi T, Yoshimura M, Rosano GMC, Lopaschuk GD and Mochizuki S: Optimization of cardiac metabolism in heart failure. Curr Pharm Des 17: 3846-3853, 2011.
9. Kim T and Yang Q: Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system. World J Cardiol 5: 164-174, 2013.
10. Planavila A, Rodriguez-Calvo R, Jové M, Michalik L, Wahli W, Laguna JC and Vázquez-Carrera M: Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovasc Res 65: 832-841, 2005.
11. Umemoto T and Fujiki Y: Ligand-dependent nucleo-cytoplasmic shuttling of peroxisome proliferator-activated receptors, PPAR and PPAR. Genes Cells 17: 576-596, 2012.
12. Scott R, O'Brien R, Fulcher G, Pardy C, D'Emden M, Tse D, Taskinen MR, Ehnholm C and Keech A; Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators: Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: The fenofibrate intervention and event lowering in diabetes (FIELD) study. Diabetes Care 32: 493-498, 2009.
13. Teshima Y, Akao M, Jones SP and Marbán E: Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 93: 192-200, 2003.
14. Echtay KS: Mitochondrial uncoupling proteins-what is their physiological role? Free Radic Biol Med 43: 1351-1371, 2007.
15. Deng S, Yang Y, Han Y, Li X, Wang X, Zhang Z and Wang Y: UCP2 inhibits ROS-mediated apoptosis in A549 under hypoxic conditions. PLoS One 7: e30714, 2012.
16. Ingwall JS: Energy metabolism in heart failure and remodelling. Cardiovasc Res 81: 412-419, 2009.
17. Askoxylakis V, Thieke C, Pleger ST, Most P, Tanner J, Lindel K, Katus HA, Debus J and Bischof M: Long-term survival of cancer patients compared to heart failure and stroke: A systematic review. BMC Cancer 10: 105, 2010.
18. Joiner ML, Koval OM, Li J, He BJ, Allamargot C, Gao Z, Luczak ED, Hall DD, Fink BD, Chen B, et al: CaMKII determines mitochondrial stress responses in heart. Nature 491: 269-273, 2012.
19. Andalib S, Shayanfar A, Khorrami A, Maleki-Dijazi N and Garjani A: Atorvastatin reduces the myocardial content of coenzyme Q10 in isoproterenol-induced heart failure in rats. Drug Res (Stuttg) 64: 246-250, 2014.
20. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G and Shah AM: Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41: 2164-2171, 2003.
21. Burkart EM, Sambandam N, Han X, Gross RW, Courtois M, Gierasch CM, Shoghi K, Welch MJ and Kelly DP: Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest 117: 3930-3939, 2007.
22. Wolins NE, Quaynor BK, Skinner JR, Tzekov A, Croce MA, Gropler MC, Varma V, Yao-Borengasser A, Rasouli N, Kern PA, et al: OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization. Diabetes 55: 3418-3428, 2006.
23. Sack MN, Rader TA, Park S, Bastin J, McCune SA and Kelly DP: Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94: 2837-2842, 1996.
24. Garnier A, Fortin D, Deloménie C, Momken I, Veksler V and Ventura-Clapier R: Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 551: 491-501, 2003.
25. Murray AJ, Anderson RE, Watson GC, Radda GK and Clarke K: Uncoupling proteins in human heart. Lancet 364: 1786-1788, 2004.
26. Noma T, Nishiyama A, Mizushige K, Murakami K, Tsuji T, Kohno M, Rahman M, Fukui T, Abe Y and Kimura S: Possible role of uncoupling protein in regulation of myocardial energy metabolism in aortic regurgitation model rats. FASEB J 15: 1206-1208, 2001.
27. Young ME, Patil S, Ying J, Depre C, Ahuja HS, Shipley GL, Stepkowski SM, Davies PJ and Taegtmeyer H: Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. FASEB J 15: 833-845, 2001.
28. Li P, Yin K, Luo SK and Cheng XS: Effect of uncoupling protein-2 on angiotensin II induced reactive oxygen species generation in mitochondria. Chinese Journal of Hypertension 18: 940-945, 2010 (In Chinese).
29. Luo SK, Li P and Cheng XS: Establishment of model of isoprenaline-induced chronic heart failure in rats. Chongqing Yixue 41: 352-354, 2012.